Skip to main content
. 2024 Jan 5;14:581. doi: 10.1038/s41598-023-50212-2

Figure 2.

Figure 2

(A) ROC curve analysis of NfL serum levels in A-ATTR-V30M patients vs. asymptomatic V30M-TTR variant carriers. (B) ROC curve analysis of NfL serum levels in A-ATTR-V30M patients vs. healthy controls.